Neema Manappuram
Medical · Chicago, ILNPI 1578173613
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 334 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Viiv Healthcare Company at 44.0% of the total. Reporting peaked in 2023 at $2,266 and has fallen 52.8% since, to $1,071 in 2025. Among medical clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 334 payments — averaging $24.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$4K
- Gilead$2K
- Merck$681
- Johnson & Johnson$595
- Janssen Products, LP$455
- Theratechnologies Inc.$217
- plus $612 from 10 others
What the payments were for
- Speaking & faculty fees$170%
- Food & beverage$8,10498%
- Education$1682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 150 | $3,647 |
| Gilead | 96 | $2,081 |
| Merck | 27 | $681 |
| Johnson & Johnson(2 entities) | 26 | $595 |
| Janssen Products, LP | 4 | $455 |
| Theratechnologies Inc. | 8 | $217 |
| Novo Nordisk | 5 | $196 |
| Exact Sciences | 4 | $94 |
| EMD Serono, Inc. | 4 | $81 |
| Organon | 2 | $56 |
| Napo Pharmaceuticals Inc | 3 | $56 |
| Lilly USA, LLC | 1 | $31 |
| AbbVie | 1 | $30 |
| Seqirus USA Inc | 1 | $30 |
| Bayer | 1 | $20 |
| Antares Pharma, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,288 in reported general payments places this provider in the 90th percentile of 449 medical providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RukobiaFostemsavir Tromethamine | 13 | $115,009 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 24 | $102,610 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 14 | $65,898 |
| ProgesteroneProgesterone, Micronized | 14 | $432 |
| Estradiol | 13 | $295 |
| Spironolactone | 11 | $127 |
| Metformin Hcl | 15 | $102 |
| Lisinopril | 11 | $25 |
| Atorvastatin Calcium | 14 | $18 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyRukobia | $3,647 | $115,00913 claims |
| GileadBiktarvy | $2,081 | $102,61024 claims |
| Janssen Products, LPSymtuza | $455 | $65,89814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 449 medical providers in Illinois.
Other medical in Chicago
- Andrea TurekChicago$145K
- Jennifer GarsonChicago$32K
- William KvasnickaChicago$19K
- Brittany WolfeChicago$12K
- Eric KingChicago$9K
- Robert RadtkeChicago$7K
- Koree RamseyChicago$5K
- Justin OkrayChicago$5K
- Alexis DavidmanChicago$5K
- Brittany RankChicago$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.